Peter Phillips’ Post

Wonder how to protect your life science IP in Germany or how to enforce your IP. This is for you:

The new "The Guide to Life Sciences: Key issues for senior life sciences executives 2023." by IAM has been published and Elena Biselli, Dr. rer. nat., Markus Grammel and Sebastian Ochs had the pleasure of contributing an article. If you want to obtain protection for your life science invention in Europe or enforce your patent in Germany, this article is for you.   #article #IAM #prosecution #lifesciences #guide

Patent eligibility and patentability are critical for life science innovators. Join us at #LSPNEurope on 21st November to get valuable insights into recent case law and strategies to overcome patentability challenges: https://ow.ly/MxYo50PHLQl

On June 17, 2024, our Kimberly Chew joined an esteemed panel to provide a detailed overview of the psychedelic patent ecosystem, covering investments, legal practices, and emerging therapies. Watch "Navigating the Psychedelic Patent Landscape: Inclusive Strategies for Innovation and Protection" today: https://lnkd.in/gPjUsmWY #Psychedelics #IntellectualProperty

April Abele Isaacson and Yifan Mao’s KTIPS session, “Hot Topics in Biopharma: From Enablement to Written Description, Section 101 Challenges and The Patent Eligibility Restoration Act of 2023,” provided an in-depth analysis of recent decisions related to enablement, written description, and patentability affecting the life sciences and other industries. This session offered a comprehensive understanding of the current legal framework, challenges, and potential legislative reforms. Watch the video here: https://lnkd.in/gxFmwDH2

Hope y'all can make this webinar today! Excellent topic

In the inaugural issue of #Synthesis: Tehrani v. Hamilton Techs - practical guidance for practitioners; challenging #USPTO’s #PTA calculation; and the #FederalCircuit considers #ClaimConstruction and its relationship to #Infringement and #Invalidity

#Synthesis: #USPTO’s guidance provides insights into #GenAI in #DrugDiscovery; #RegenxBio departs from previous case law. #PatentEligibility #NucleicAcid #Inventorship #LifeSciences #IntellectualProperty

#Synthesis: #USPTO’s guidance provides insights into #GenAI in #DrugDiscovery; #RegenxBio departs from previous case law. #PatentEligibility #NucleicAcid #Inventorship #LifeSciences #IntellectualProperty

Haven't had time to watch our June seminar on IP protection in its entirety? Fear not, we've got you covered! We've condensed two hours into just five minutes, bringing you the most important highlights from our panelists and speakers. Our recap will give you a snapshot of the most insightful comments on the strengths and challenges facing the Swedish life science industry in light of the proposed legislative changes. #LifeScience #IPRights #EUlegislation